The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer
Abstract
BACKGROUND: Screening with mammography has been shown by randomized controlled trials to reduce breast cancer mortality in women aged 40 to 74 years. Estimates from observational studies following screening implementation in different countries have produced varyied findings. We report findings for seven Canadian breast screening programs. METHODS: Canadian breast screening programs were invited to participate in a study aimed at comparing breast cancer mortality in participants and nonparticipants. Seven of 12 programs, representing 85% of the Canadian population, participated in the study. Data were obtained from the screening programs and corresponding cancer registries on screening mammograms and breast cancer diagnoses and deaths for the period between 1990 and 2009. Standardized mortality ratios were calculated comparing observed mortality in participants to that expected based upon nonparticipant rates. A substudy using data from British Columbia women aged 35 to 44 years was conducted to assess the potential effect of self-selection participation bias. All statistical tests were two-sided. RESULTS: Data were obtained on 2796472 screening participants. The average breast cancer mortality among participants was 40% (95% confidence interval [CI] = 33% to 48%) lower than expected, with a range across provinces of 27% to 59%. Age at entry into screening did not greatly affect the magnitude of the average reduction in mortality, which varied between 35% and 44% overall. The substudy found no evidence that self-selection biased the reported mortality results, although the confidence intervals of this assessment were wide. CONCLUSION: Participation in mammography screening programs in Canada was associated with substantially reduced breast cancer mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380 · cited 1×
“Forest plots were used to display results, and tests of homogeneity of rates were made using Q (22) and I2 (23,24) and were two-sided, with analysis performed using the rmeta routine in the R statistical package (25).”
MethodCancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
The benefits and harms of breast cancer screening: an independent review
(2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,492
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,367
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
The Canadian Task Force on Preventive Health Care
Aguilar, J. R. G. (2012) · Cited by 413
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
All-Cause Mortality in Randomized Trials of Cancer Screening
Black, W. C. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.167 · Cited by 390
Recommendations on screening for breast cancer in average-risk women aged 40-74 years
The Canadian Task Force on Preventive Health Care (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110334 · Cited by 348
Autier, P., Boniol, M., Gavin, A., & Vatten, L. J. (2011) · BMJ · doi:10.1136/bmj.d4411 · Cited by 300
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182978e4a · Cited by 244
How effective are breast cancer screening programmes by mammography? Review of the current evidence
Schopper, D., & de Wolf, C. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.03.022 · Cited by 169
Miller, A. B., Baines, C. J., & Wall, C. (2015) · Cited by 123
Evaluation of periodic breast cancer screening with mammography. Methodology and early observations
Shapiro, S. (1966) · JAMA · doi:10.1001/jama.195.9.731 · Cited by 99
Breast cancer mortality after screening mammography in British Columbia women
Coldman, A. J., Phillips, N., Warren, L. J., & Kan, L. (2006) · International Journal of Cancer · doi:10.1002/ijc.22249 · Cited by 96
Self-citationEvaluation of Periodic Breast Cancer Screening With Mammography
Shapiro, S. (1966) · JAMA · doi:10.1001/jama.1966.03100090065016 · Cited by 65
Moss, S. M., Summerley, M. E., Thomas, B., Ellman, R., & Chamberlain, J. (1992) · Journal of Epidemiology & Community Health · doi:10.1136/jech.46.4.362 · Cited by 54
Coldman, A. J., & Phillips, N. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121791 · Cited by 45
Self-citationThe impact of advances in treatment on the efficacy of mammography screening
Jatoi, I. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.06.012 · Cited by 34
Lawrence, G., O’Sullivan, E., Kearins, O., Tappenden, N., Martin, K. L., & Wallis, M. (2009) · Journal of Medical Screening · doi:10.1258/jms.2009.009040 · Cited by 28
Re: All-Cause Mortality in Randomized Trials of Cancer Screening
Gail, M. H., & Katki, H. A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.862 · Cited by 14
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
Metadata
- Authors
- Coldman, A., Phillips, N., Wilson, C., Decker, K., Chiarelli, A. M., Brisson, J., Zhang, B., Payne, J., Doyle, G., & Ahmad, R.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-01
- Volume
- 106
- Issue
- 11
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2150061011
- Cited by
- 295
- References
- 28
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.